Increase In Working Memory Errors Research Articles

Hippocampal α7 and α4β2 nicotinic receptors and working memory

Nicotine and other nicotinic receptor agonists have been found in a variety of studies to improve memory, while nicotinic receptor blockade can impair memory. The critical neural mechanisms for nicotinic involvement with memory are still under investigation. Initial evidence supports the involvement of the ventral hippocampus. Lesions in this area block nicotine-induced memory improvement and mecamylamine-induced impairment. Local ventral hippocampal application of the nicotinic channel blocker mecamylamine impairs memory in the 8-arm radial maze. Both α4β2 and α7 nicotinic receptors seem to be involved. Ventral hippocampal infusions of high doses of the α4β2 nicotinic antagonist dihydro-β-erythrodine (DHβE) and the α7 nicotinic antagonist methyllycaconitine (MLA) impair memory performance on the 8-arm radial maze. However, high doses of these drugs may limit specificity and they cause preconvulsant effects, which in themselves may affect memory. The current study used the more challenging 16-arm radial maze to determine the effects of lower doses of these drugs on memory and to differentiate effects on working and reference memory. Adult female Sprague–Dawley rats were trained on a working and reference memory task in the 16-arm radial maze and then were implanted with bilateral chronic guide cannulae directed to the ventral hippocampus. After recovery from surgery, the rats received acute intrahippocampal infusions of dose combinations of DHβE and MLA. In the first study, DHβE (0 and 6.75 μg/side) and MLA (0, 6.75, 13.5 and 27 μg/side) were administered in a counter-balanced order. In the second study, lower doses of DHβE (0, 1.6375, 3.275 and 6.75 μg/side) were administered alone or with MLA (0 and 6.75 μg/side) in a counter-balanced order. In the first study, DHβE caused a significant increase in both working and reference memory errors. MLA at a dose of 27 μg/side caused a significant increase in working memory errors, but this dose had no significant effect on reference memory errors. Interestingly, no additive effects were seen with combined administration of DHβE and MLA in this study, and at the doses used, no effects were seen on response latency. In the second study, lower doses of DHβE did not cause a significant deficit in working memory performance. Co-administration of MLA with these subthreshold doses did precipitate a memory impairment. The current results confirm the specificity of the memory deficits caused by these drugs. These results support the involvement of α4β2 and α7 nicotinic receptors in the ventral hippocampus as being critical for memory function.